Lensar (LNSR) Cash & Current Investments (2019 - 2026)
Lensar (LNSR) reported Cash & Current Investments of $13.5 million for Q1 2026, down 46.55% year-over-year from $25.2 million in Q1 2025, and down 24.94% quarter-over-quarter from $18.0 million in Q4 2025.
Lensar (LNSR) Cash & Current Investments (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Cash & Current Investments data on file, last reported at $13.5 million in Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $13.5 million, down 46.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.5 million (down 46.55% YoY), and the FY2025 annual result was $18.0 million, down 5.45% from the prior year.
- Cash & Current Investments slipped to $13.5 million in Q1 2026 per LNSR's latest filing, from $18.0 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $29.0 million in Q1 2022 and troughed at $13.5 million in Q1 2026.
- A 5-year average of $20.9 million and a median of $19.1 million in 2024 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2022 and 2025: Cash & Current Investments plunged 53.62% in 2022, then jumped 53.31% in 2025.
- A 5-year view of Cash & Current Investments shows it stood at $14.7 million in 2022, then surged by 46.78% to $21.5 million in 2023, then decreased by 11.72% to $19.0 million in 2024, then dropped by 5.45% to $18.0 million in 2025, then declined by 24.94% to $13.5 million in 2026.
- Business Quant data shows LNSR's Cash & Current Investments at $13.5 million in Q1 2026, $18.0 million in Q4 2025, and $16.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 8.38 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 3.67 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 2.29 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.12 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 1.12 Bn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Lensar | 70.41 Mn | 70.70 Mn | 6.38 Mn | 13.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.50 Mn |
| Dec 31, 2025 | 17.98 Mn |
| Sep 30, 2025 | 16.87 Mn |
| Jun 30, 2025 | 28.22 Mn |
| Mar 31, 2025 | 25.25 Mn |
| Dec 31, 2024 | 19.02 Mn |
| Sep 30, 2024 | 18.08 Mn |
| Jun 30, 2024 | 18.41 Mn |
| Mar 31, 2024 | 19.26 Mn |
| Dec 31, 2023 | 21.54 Mn |
| Sep 30, 2023 | 24.92 Mn |
| Jun 30, 2023 | 25.47 Mn |
| Dec 31, 2022 | 14.67 Mn |
| Mar 31, 2022 | 28.98 Mn |
| Dec 31, 2021 | 31.64 Mn |
| Sep 30, 2021 | 32.34 Mn |
| Jun 30, 2021 | 34.55 Mn |
| Mar 31, 2021 | 35.87 Mn |
| Dec 31, 2020 | 40.60 Mn |
| Sep 30, 2020 | 42.70 Mn |